Evidence map›Paper›PMID 25897795›Full record

Observational studyAtherosclerosis2015

Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort.

João D Fontes, Faisal Rahman, Sean Lacey, Martin G Larson, Ramachandran S Vasan, Emelia J Benjamin, William S Harris, Sander J Robins

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Atherosclerosis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

João D FontesNational Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Cardiology and Preventive Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Faisal RahmanBoston University Medical Center, Boston, MA 02118, USA.
Sean LaceyNational Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA.
Martin G LarsonNational Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Mathematics and Statistics, Boston University, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Ramachandran S VasanNational Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Cardiology and Preventive Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Epidemiology Department, Boston University School of Public Health, Boston, MA, USA.
Emelia J BenjaminNational Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Cardiology and Preventive Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Epidemiology Department, Boston University School of Public Health, Boston, MA, USA.
William S HarrisDepartment of Medicine, Sanford School of Medicine, University of South Dakota, and OmegaQuant Analytics, LLC, 5009 W. 12th St, Ste 8, Sioux Falls, SD 57106, USA. Electronic address: bill@omegaquant.com.
Sander J RobinsNational Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Cardiology and Preventive Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Boston University · USNational Heart Lung and Blood Institute · USUniversity of South Dakota · US

Funding

IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Framingham: Inflammation, Genes &Cardiovascular DiseaseR01HL076784 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2004 to 2008
$3.9M
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham StudyR01AG028321 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2006 to 2010
$1.8M
INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAMR01HL064753 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2000 to 2003
$1.2M
Red Blood Cell Fatty Acid Biomarkers and Cardiovascular Disease RiskR01HL089590 · NHLBI · SANFORD RESEARCH/USD · PI HARRIS, WILLIAM S · 2008 to 2011
$683k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS 1R01-HL64753NHLBI NIH HHS 2R01HL092577NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01-HC 25195NHLBI NIH HHS N01-HC25195NHLBI NIH HHS R01 HL076784NHLBI NIH HHS R01-HL076784NHLBI NIH HHS R01 HL089590NHLBI NIH HHS R01 HL092577NIA NIH HHS 1R01-AG0283211NIA NIH HHS R01 AG028321
6 · The paper itself

Abstract

introductionInflammation and inflammatory biomarkers have emerged as integral components and predictors of incident cardiovascular (CV) disease. Omega-3 fatty acids, particularly eicosapentaenoic and docosahexaenoic acids (EPA and DHA) have anti-inflammatory properties, and have been variably associated with lower blood pressure, favorable blood lipid changes, and reduced CV events. METHODS AND

resultsWe examined the cross-sectional association of red blood cell (RBC) fatty acids, representative of body membrane fatty acid composition, with 10 biomarkers active in multiple inflammatory pathways in 2724 participants (mean age 66 ± 9 years, 54% women, 8% minorities) from the Framingham Offspring and minority Omni Cohorts. After multivariable adjustment, the RBC EPA and DHA content was inversely correlated (all P ≤ 0.001) with 8 biomarkers: urinary isoprostanes (r = -0.16); and soluble interleukin-6 (r = -0.10); C-reactive protein (r = -0.08); tumor necrosis factor receptor 2 (r = -0.08); intercellular adhesion molecule-1 (r = -0.08); P-selectin (r = -0.06); lipoprotein-associated phospholipase-A2 mass (r = -0.11) and activity (r = -0.08). The correlations for monocyte chemoattractant protein-1 was -0.05, P = 0.006 and osteoprotegerin (r = -0.06, P = 0.002) were only nominally significant.

conclusionIn our large community-based study, we observed modest inverse associations between several types of inflammatory biomarkers with RBC omega-3 fatty acid levels. Our findings are consistent with the hypothesis that omega-3 fatty acids have anti-inflammatory properties.

Indexed as

AgedAnti-Inflammatory AgentsBiomarkersCross-Sectional StudiesDocosahexaenoic AcidsEicosapentaenoic AcidErythrocytesFemaleHumansInflammationInflammation MediatorsMaleMiddle AgedMultivariate AnalysisProtective FactorsRisk FactorsAnti-Inflammatory AgentsBiomarkersDocosahexaenoic AcidsEicosapentaenoic AcidInflammation MediatorsBiomarkersCross-sectional studyInflammationOmega-3 fatty acids

Identifiers

PMID25897795
PMCPMC4511480
OpenAlexW2076600451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.